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Insulin secretion: Feed-forward control of insulin biosynthesis?
Guy A. Rutter
It has long been accepted wisdom that insulin secreted
from islet β cells has either no effect, or an inhibitory
feedback effect, on insulin synthesis and secretion.
Recent work suggests, instead, that secreted insulin
acts directly on β cells, via its own receptor, to enhance
insulin production in an autocrine feed-forward loop.
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Insulin, the body’s chief anabolic hormone, is synthesised
in pancreatic islets, and released when the blood glucose
level rises. Defective insulin release contributes to non-
insulin-dependent diabetes mellitus (NIDDM). A new
study has now shown that targeted inactivation of insulin
receptors in pancreatic β cells, by genetic manipulation of
mice using the Cre–loxP system, produces animals which
suffer insulin secretory defects akin to those found in
human patients with NIDDM [1]. Furthermore, in vitro
studies have shown that exogenous insulin added directly
to normal islets causes transcriptional up-regulation of the
preproinsulin gene [2], activation of protein translational
machinery [3] and insulin secretion [4]. The important
implication is that insulin acts back on the β cells to
promote its own production.
Insulin biosynthesis
In mammals, an increase in the blood glucose level
enhances transcription of the preproinsulin gene [5] and
translation of preproinsulin mRNA [6], and stimulates the
release of insulin by regulated exocytosis of the mature
hormone. The latter process, which resembles the
regulated release of neurotransmitters from neurons,
involves Ca2+ influx through L-type channels, an increase
in intracellular Ca2+ concentration and exocytosis from
dense-core secretory vesicles (Figure 1) [7].
Is secreted insulin involved in stimulating insulin gene
expression? Certainly, the order of events in response to
glucose is compatible with this idea. Insulin secretion is
activated seconds to minutes after an elevation in the
glucose level, preproinsulin mRNA translation is activated
within minutes, and transcription of the gene is activated
after about an hour [8]. Before we can conclude that
insulin plays an important role in this process, however, a
number of other criteria must be also be satisfied: block-
ade of insulin receptor function in islet β cells should
impair insulin production; addition of exogenous insulin to
islets incubated in vitro should enhance preproinsulin
gene expression (through activation of transcription, trans-
lation or both); and changes in preproinsulin gene expres-
sion should parallel changes in insulin secretion.
Generation of β-cell insulin receptor knock-out mice
Kulkarni et al. [1] have addressed the first of these points
in intact mice by ablating insulin receptors — members of
the receptor tyrosine kinase family — specifically in islet β
cells. To do this, they first targeted expression of the Cre
recombinase enzyme specifically to islet β cells using the
rat insulin promoter. Cre recombinase is capable of remov-
ing transgenes inserted between specific sequences,
known as loxP sites. The resulting animals were bred with
transgenic mice in which exon 4 of the insulin receptor
gene was flanked with loxP sites. In the progeny carrying
both the Cre and loxP constructs, excision of exon 4 in β
cells resulted in the production — in these cells only — of
truncated, non-functional insulin receptors. Crucially,
pancreatic islet development was normal in these ‘βIRKO’
animals, although a decline in pancreatic insulin content
and islet size was observed with age.
Τhe βIRKO animals are not overtly diabetic, and display
only mild hyperinsulinaemia. But in contrast to mice
lacking muscle insulin receptors [9], they display reduced
glucose tolerance and a drastically reduced ‘first phase’ of
insulin secretion — classical features of NIDDM in
humans. This may indicate that there are effects of
insulin, not only on the preproinsulin gene, but on other β
cell genes as well. These may include genes encoding key
‘glucose sensing’ enzymes, such as glucokinase, the
glucose transport GLUT2 and lactate dehydrogenase [10],
so that a defect in the regulation would lead to abnormal
glucose metabolism. Any such effects on the expression of
these genes may be a consequence of transcription factor
dysregulation, as has been observed in certain forms of the
disorder known as ‘maturity-onset diabetes of the young’
[11]. In vitro studies with islets from βIRKO animals will
be necessary to determine whether this is the case.
A direct effect on preproinsulin gene expression?
Using reporter constructs encoding the green fluorescent
protein (GFP) [12], Leibiger et al. [2] showed that short
incubations of isolated rat islets or HIT-T15 insulinoma
cells with physiological concentrations of insulin activated
transcription directed by the insulin promoter. Other
studies have examined the effects of insulin on the tran-
scription factor known as ‘pancreatic duodenum Xenopus
homeodomain factor-1’ (PDX-1) [13] — variously known
by the alternative names IPF-1, IDX-1, STF-1 or IUF1 —
a key player in the regulation of insulin promoter activity
[14]. MacFarlane et al. [15] have recently found that
PDX-1 binding to cognate DNA is stimulated in human
islets by added insulin, apparently mimicking the effect of
glucose. Whether insulin, like glucose, causes translocation
of PDX-1 to the nucleoplasm [14,15] is as yet untested. 
One further molecular target of insulin may be the
phosphoprotein known as ‘phosphorylated heat- and acid-
stable protein regulated by insulin’ (PHAS-I), a regulator
of translation initiation. Xu et al. [3] have recently shown
that the phosphorylation state of this protein in pancreatic
islets is increased by exposure to glucose or exogenous
insulin, an action predicted to enhance the translation of
preproinsulin mRNA. 
Are there parallel effects of glucose on insulin secretion
and preproinsulin gene expression?
In contrast to recent findings described above, which have
provided compelling evidence for a role of secreted
insulin in the regulation of gene expression, studies of
insulin secretion have provided a less clear-cut picture.
Indeed, the intracellular signalling pathways leading to
insulin exocytosis, on the one hand, and to enhanced gene
expression, on the other, have long been thought to be
distinct. Work more than twenty-five years ago [16]
showed that insulin biosynthesis, as measured through
incorporation of radiolabelled leucine, displays a lower
threshold than secretion for glucose activation, and is
unaffected by removal of extracellular Ca2+ ions. The role
of Ca2+ is particularly important in this context, as block-
ade of Ca2+ influx inhibits glucose-induced insulin secre-
tion under most conditions by at least 95%. Furthermore,
increases in intracellular [Ca2+], and activation of secretion
by the oral antihyperglycaemic agent tolbutamide, have
no effect on insulin biosynthesis measured this way [6]. 
These measurements chiefly reflect preproinsulin mRNA
translation, which would therefore appear not to be 
regulated by secreted insulin. But this does not exclude a
role for insulin in the activation of preproinsulin gene tran-
scription. Here, the role of intracellular Ca2+ concentration
— and therefore potentially of secreted insulin — is much
more controversial. Thus, in a recent study using GFP
reporter genes imported into islets from adult rats using
adenovirus vectors [17], no effect of pharmacological
Ca2+ channel blockade with verapamil was observed on
insulin promoter activity. Similarly, others observed only
small effects of inhibiting Ca2+ influx on insulin promoter
activity in HIT-T15 insulinoma [18] and INS-1 cells
(G.A.R. and H.J. Kennedy, unpublished data). Clear
effects were, however, seen in transfected foetal islets [19]
and in β-TC3 insulinoma cells [20]. 
Most recently, Leibiger et al. [2] observed that Ca2+
channel blockade with nimodipine reversed glucose-
induced increases in preproinsulin gene promoter activity
and mRNA levels in islets and HIT-T15 cells. Further-
more, the effects of glucose (and of insulin) could be mim-
icked by increasing Ca2+ influx. By contrast, Docherty’s
group has found that PDX-1 binding to DNA is not
affected by Ca2+ removal, nor mimicked by Ca2+ influx
(K. Docherty, personal communication). Similarly, inhibi-
tion of phosphatidylinositol 3-kinase (PI 3-kinase) with
wortmannin blocked glucose-activated DNA binding by
PDX-1 completely at wortmannin concentrations that do
not affect glucose-stimulated insulin release. Thus there is
much evidence, at least in vitro, to cast doubt on a simple
scheme in which secreted insulin is alone responsible for
activation of the preproinsulin gene by glucose.
An acute effect of insulin on its own secretion?
The question of whether insulin has an acute effect on its
own secretion has been the most studied aspect of insulin’s
influence on pancreatic islets. Here again, the picture is
complicated by the number and type of preparations used.
Most early studies showed a clear inhibitory effect on
secretion of added insulin, in static incubation of rat islets
[21], in the perfused pancreas [22] or after intravenous
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Figure 1
The possible interplay between the action of
glucose (top left) and secreted insulin (red
squares) on preproinsulin gene expression in
the islet β cell. (See text for details.)
Verapamil,
nimodipine
ATP
K+
Ca2+
IRS-1/IRS-2?
PI 3-kinase PDX-1
Insulin
Insulin
receptor
Glucose 6-phosphate
Glucose
Cytoplasm
Rap
p70S6K?
SAPK?
Wortmannin
SB 203580
Current Biology  
Nucleus
Preproinsulin
gene
?
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[23]. Other data, however, have suggested there is no acute
effect of insulin, or an effect that requires pancreatic inner-
vation, on insulin secretion [24]. Using amperometry to
detect insulin secreted from single β cells, Aspinwall et al.
[4] have recently observed that insulin directly and rapidly
activates its own secretion.
Conclusions
Taken together, the above data suggest a scheme for the
regulation of preproinsulin gene expression that is illus-
trated in Figure 1. What intracellular signalling pathways
may be involved downstream of the insulin receptor in
β cells? At this stage, the pharmacological data are still con-
troversial. It seems likely that glucose and insulin may act
through separate pathways initially, perhaps converging
downstream on a common pathway. The reported effects
of wortmannin, sensitivity to rapamycin and a lack of effect
of dominant-negative forms of protein kinase B [2] indicate
the action of a signalling pathway from the insulin receptor
that involves PI 3-kinase, protein kinase p70, S6 kinase and
a stress-activated protein kinase (SAPK) [15]. Importantly,
such a scheme could explain the observed β cell defects
observed in mutant mice lacking insulin receptor substrate-
2 (IRS-2), a known downstream target of the insulin recep-
tor [25]. It will be important to determine how far the
effects of insulin and glucose are additive, as it may be that
secreted insulin acts largely to potentiate the effects of sub-
maximal glucose concentrations. As a result, defective
action of insulin on the β cell — ‘insulin resistance’ — may
be an important contributor to the pathology of NIDDM.
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